Publicaciones en las que colabora con EDORTA SANTOS VIZCAINO (11)

2024

  1. Laponite nanoclays for the sustained delivery of therapeutic proteins

    European Journal of Pharmaceutical Sciences, Vol. 201

2022

  1. Hybrid 3D Printed and Electrospun Multi-Scale Hierarchical Polycaprolactone Scaffolds to Induce Bone Differentiation

    Pharmaceutics, Vol. 14, Núm. 12

2021

  1. Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 498-514

  2. Polycaprolactone hybrid scaffolds combining 3D printing and electrospinning to guide the osteogenic differentiation of MC3T3 preosteoblasts for bone tissue regeneration

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 30-32

2020

  1. 3D encapsulation and inflammatory licensing of mesenchymal stromal cells alter the expression of common reference genes used in real-time RT-qPCR

    Biomaterials Science, Vol. 8, Núm. 23, pp. 6741-6753

  2. Mesenchymal stromal cell based therapies for the treatment of immune disorders: recent milestones and future challenges

    Expert Opinion on Drug Delivery, Vol. 17, Núm. 2, pp. 189-200

  3. Multifunctional biomimetic hydrogel systems to boost the immunomodulatory potential of mesenchymal stromal cells

    Biomaterials, Vol. 257

2019

  1. Extracellular matrix protein microarray-based biosensor with single cell resolution: Integrin profiling and characterization of cell-biomaterial interactions

    Sensors and Actuators, B: Chemical, Vol. 299

  2. Monitoring implantable immunoisolation devices with intrinsic fluorescence of genipin

    Journal of Biophotonics, Vol. 12, Núm. 4

2017

  1. Cell microencapsulation technology: Current vision of its therapeutic potential through the administration routes

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 49-62

  2. The role of osmolarity adjusting agents in the regulation of encapsulated cell behavior to provide a safer and more predictable delivery of therapeutics

    Drug Delivery, Vol. 24, Núm. 1, pp. 1654